American Heart Association comments on President Biden’s nomination for Secretary of Health and Human Services, Xavier Beccera, who will appear in a hearing before the Senate Committee on Health, Education, Labor and Pensions and the Senate Committee on Finance on February 23.
President Biden’s nominee for Secretary of Health and Human Services (HHS), Xavier Becerra, will appear before the Senate Committee on Health, Education, Labor and Pensions and the Senate Committee on Finance for confirmation hearings February 23.
Becerra, who currently serves as California's attorney general, will have his hearing follow another of Biden's pick for U.S. attorney general, judge Merrick Garland. His hearing will be followed by a second hearing on Tuesday.
Biden has more than two dozen nominees in his cabinet still waiting to be confirmed by the Senate.
If confirmed, Becerra will be the first Latino to lead the department.
It's significant to add he is a former member of Congress who has already played a critical part in national healthcare issues, having been the chief defender of the Affordable Care Act in court.
American Heart Association (AHA) CEO Nancy Brown said the Biden administration has made the COVID-19 pandemic its top public health priority, and the AHA remains committed to providing the public and healthcare providers with trusted, science-based tools and resources that empower us to defeat virus and address the health disparities that have been laid bare by the pandemic.
“The Secretary of Health and Human Services has an essential role to play both in the ongoing public health response and in the work to shape our healthcare system for the future to ensure equitable healthcare for everyone in America," Brown added.
To achieve this goal, Brown said the HHS must:
“Our commitment to equitable health for everyone requires us to address racial and economic inequities aimed at improving access to quality healthcare, preventing tobacco and nicotine use, funding cardiovascular disease research and prevention programs and encouraging healthy eating and active living," Brown said. "We look forward to working with Xavier Becerra, if confirmed, to protect and improve the health of everyone in this country, consistent with our mission to be a relentless force for longer, healthier lives.”
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with Ceci Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
The Departments of Health and Human Services (HHS), Labor, and the Treasury, released final rules on short-term, limited-duration insurance (STLDI) and independent, non-coordinated excepted benefits coverage, addressing issues related to the low-quality insurance, or "junk insurance" plans.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and Ceci Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 28th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More